UK markets open in 5 hours 24 minutes
  • NIKKEI 225

    27,926.80
    +352.37 (+1.28%)
     
  • HANG SENG

    19,508.65
    +58.42 (+0.30%)
     
  • CRUDE OIL

    72.01
    +0.55 (+0.77%)
     
  • GOLD FUTURES

    1,804.30
    +2.80 (+0.16%)
     
  • DOW

    33,781.48
    +183.56 (+0.55%)
     
  • BTC-GBP

    14,062.88
    +264.49 (+1.92%)
     
  • CMC Crypto 200

    406.33
    +11.64 (+2.95%)
     
  • ^IXIC

    11,082.00
    +123.45 (+1.13%)
     
  • ^FTAS

    4,082.24
    -11.44 (-0.28%)
     

Genomics In Cancer Care Global Market to Grow by 19.72% Annually Through 2029

Company Logo
Company Logo

Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Genomics In Cancer Care Market Analysis by Product, by Application, by Technology, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The genomics in cancer care market size is estimated to be USD 10,354 million in 2021 and is expected to witness a CAGR of 19.72% during the forecast period 2022-2029. The rising demand for diagnostics and the availability of technologically improved and cost-effective diagnostic technology are some of the key drivers for the market growth. Furthermore, rising investments in the biotech and pharmaceutical industries, and increased R&D activities for the development of novel treatment treatments is expected to contribute the market growth. However, lack of skilled professional is expected to restrain the market growth.

Regional Markets

In 2021, North America region accounted for the highest revenue in the genomics in cancer care market and is expected to maintain its dominance during the forecast period. This is attributed to higher level of knowledge regarding cancer genomics and a rising biotechnology industry.Some of the key players operating in the genomics in cancer care market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and BGI (China).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, application, technology, and end user from 2021 to 2029.

Segmentation: Genomics in Cancer Care Market Report 2021-2029
Product (Revenue, USD Million)

  • Services

  • Instruments

  • Consumables

By Application (Revenue, USD Million)

  • Research

  • Personalized Medicine

  • Diagnostics

  • Drug Discovery & Development

By Technology (Revenue, USD Million)

  • Microarray

  • Genome Sequencing

  • PCR

  • Nucleic Acid Extraction and Purification

By End user (Revenue, USD Million)

  • Research Institutes

  • Hospitals

  • Academic Institutes

By Region (Revenue, USD Million)
North America

  • U.S

  • Canada

Europe

  • Germany

  • France

  • UK

  • Spain

  • Italy

  • Rest of Europe

Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of APAC

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of LATAM

Middle East & Africa

  • South Africa

  • GCC

  • Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Genomics In Cancer Care

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Genomics In Cancer Care Market

7. Market Analysis by Product

8. Market Analysis by Application

9. Market Analysis by Technology

10. Market Analysis by End user

11. Regional Market Analysis

12. North America Genomics In Cancer Care Market

13. Europe Genomics In Cancer Care Market

14. Asia Pacific Genomics In Cancer Care Market

15. Latin America Genomics In Cancer Care Market

16. MEA Genomics In Cancer Care Market

17. Competitor Analysis

18. Company Profiles

19. Conclusion & Recommendations

Companies Mentioned

  • Illumina Inc. (US)

  • Thermo Fisher Scientific (US)

  • QIAGEN N.V. (Netherlands)

  • Agilent Technologies Inc. (US)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Bio-Rad Laboratories Inc. (US)

  • BGI (China).

For more information about this report visit https://www.researchandmarkets.com/r/pxdxjf

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900